Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/1995
07/13/1995WO1995018617A1 1-aminoindan derivatives and compositions thereof
07/13/1995WO1995018616A2 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
07/13/1995WO1995018615A1 A method of treating neurogenic inflammation
07/13/1995CA2180239A1 A method of treating neurogenic inflammation
07/13/1995CA2180238A1 Novel heterocyclic compounds
07/13/1995CA2180122A1 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the usethereof as antagonists for the glycine/nmda receptor
07/12/1995EP0662471A2 Naphthalene derivatives with affinity to the receptors of melatonine, process for their preparation and pharmaceutical compositions containing them
07/12/1995EP0662092A1 Activity-dependent neurotrophic factor
07/12/1995EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor
07/12/1995EP0662081A1 Ureido-acetamide derivatives, preparation thereof and drugs containing same.
07/12/1995EP0662003A1 Oligonucleotide modulation of cell adhesion
07/12/1995EP0661973A1 Method of preventing nmda receptor complex-mediated neuronal damage
07/12/1995EP0661971A1 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
07/12/1995EP0661970A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
07/12/1995EP0615452A4 Medicament for promoting growth of mammalian nerve.
07/12/1995EP0573548B1 Neuroprotectant agents
07/12/1995EP0463139B1 2,13-disubstituted ergolins, their preparation and their use in drugs
07/12/1995CN1105016A Triglycerides
07/12/1995CN1104911A Preparation for hypnotism agent
07/12/1995CN1104889A Cessation of tobacco use
07/11/1995US5432177 Treatment of psychotic disorders
07/11/1995US5432173 Psychological disorders
07/11/1995US5432164 C2,N6 -disubstituted adenosine derivatives
07/11/1995CA2113143A1 Extract and process for the preparation of this extract
07/11/1995CA1336287C Selective serotonin uptake inhibitors
07/07/1995CA2137998A1 Antimigraine derivatives of indolylcycloalkanylamines
07/06/1995WO1995018129A1 Diazabicyclic neurokinin antagonists
07/06/1995WO1995018128A1 Pyrazolopyridine adenosine antagonists
07/06/1995WO1995018124A1 Substituted morpholine derivatives and their use as therapeutic agents
07/06/1995WO1995018118A1 Heterocyclic compounds for the treatment of cns and cardiovascular disorders
07/06/1995WO1995018114A1 Benzoxazine derivatives, methods for obtaining same and their use as drugs
07/06/1995WO1995018105A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists
07/06/1995WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
07/06/1995WO1995017904A2 Botulinum toxins for treating various disorders and associated pain
07/06/1995WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules
07/06/1995WO1995017890A1 Method of treatment of traumatic brain injury
07/06/1995WO1995017876A2 2,4-disulphophenyl butylnitrone, its salts, and their use as pharmaceutical spintraps
07/06/1995CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition
07/06/1995CA2180253A1 Pyrazolopyridine adenosine antagonists
07/06/1995CA2179824A1 Method of treatment of traumatic brain injury
07/06/1995CA2176722A1 Heterocyclic compounds for the treatment of cns and cardiovascular disorders
07/05/1995EP0660833A1 3,3'-DISUBSTITUTED-1,3-DIHYDRO-2H-PYRROLO 2,3-b]HETEROCYCLIC-2-ONE USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS OF MAN
07/05/1995EP0660832A1 Serotonin receptor agents
07/05/1995EP0660718A1 Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium
07/05/1995EP0660707A1 Method of preventing nmda receptor-mediated neuronal damage
07/05/1995CN1104634A Compounds with a sulphamoyl and amidino group, process for preparing them and pharmaceutical compositions containing them
07/05/1995CN1104497A Triglycerides
07/05/1995CN1104496A Internal radiation damage
07/05/1995CN1104494A Schizophrenia
07/05/1995CN1104492A Anti-inflammatory analgesic plaster
07/05/1995CN1029227C Composition for denatured denaturation or protection agent for nerve cell and process for preparing benzene derivatives used for composition
07/04/1995US5430063 Phenoxyphenyl derivatives, compositions thereof and methods for their use
07/04/1995US5430060 Aldose reductase inhibitor
07/04/1995US5430031 Serotoninergic ergoline derivatives
07/04/1995US5430029 Pharmaceutical compositions active in the therapy of sleep disorders
07/04/1995US5430027 2-chloro-N6 -substituted adenosines, their pharmaceutical compositions, and activity in treating ischemias
07/04/1995CA1336195C Aryloxyphenylpropylamines and their preparation and use
07/04/1995CA1336169C Agent for treatment of parkinson's disease
06/1995
06/29/1995WO1995017423A1 Compounds with growth hormone releasing properties
06/29/1995WO1995017422A1 Compounds with growth hormone releasing properties
06/29/1995WO1995017410A1 Heterocyclic compounds
06/29/1995WO1995017406A1 Anticonvulsant pseudofructopyranose sulfamates
06/29/1995WO1995017405A1 Indoline derivatives, method of preparation and their use as pharmaceuticals
06/29/1995WO1995017402A1 New pyridazino[4',5':3,4]pyrrolo-[2,1-a]isoquinolines and their use for preparing pharmaceutical compositions
06/29/1995WO1995017401A1 Dyhydrobenzofuranyl-biphenyl carboxamides having 5ht1d antagonistic activity
06/29/1995WO1995017400A1 N-heterobicyclyl-piperazinyl or-piperadinyl tricyclic derivatives useful as dopamine receptor ligands
06/29/1995WO1995017398A1 Indole, indoline and quinoline derivatives with 5ht1d (anti-depressive) activity
06/29/1995WO1995017389A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
06/29/1995WO1995017388A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
06/29/1995WO1995017385A1 N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs
06/29/1995WO1995017384A1 4-arylisoindole analgesics
06/29/1995WO1995017382A1 Non-peptide tachykinin receptor antagonists
06/29/1995WO1995017204A1 Composition and methods to improve neural outcome
06/29/1995WO1995017197A1 Vitamin d3 analogues and pathway to mediate disorders
06/29/1995WO1995017185A1 A method of treating gastrointestinal motility disorders
06/29/1995WO1995017183A1 Use of pla2 inhibitors as treatment for alzheimer's disease
06/29/1995WO1995017182A1 Protein kinase c inhibitors
06/29/1995WO1995017095A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
06/29/1995CA2179735A1 N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs
06/29/1995CA2179649A1 Use of pla2 inhibitors as treatment for alzheimer's disease
06/29/1995CA2179598A1 Compounds with growth hormone releasing properties
06/29/1995CA2179597A1 Compounds with growth hormone releasing properties
06/29/1995CA2179491A1 A method of treating gastrointestinal motility disorders
06/29/1995CA2179402A1 Indoline derivatives, method of preparation and their use as pharmaceuticals
06/29/1995CA2179288A1 Vitamin d3 analogues and pathway to mediate disorders
06/29/1995CA2178711A1 Composition and methods to improve neural outcome
06/29/1995CA2178209A1 Anellated dihydropyridines and the use thereof for preparing pharmaceutical preparations
06/29/1995CA2178094A1 New pyridazino[4',5':3,4]pyrrolo-[2,1-a]isoquinolines and their use for preparing pharmaceutical compositions
06/29/1995CA2178088A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
06/29/1995CA2177851A1 Heterocyclic compounds
06/29/1995CA2176130A1 Non-peptide tachykinin receptor antagonists
06/29/1995CA2176127A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
06/28/1995EP0659747A1 Branched aminothiazole derivatives process for their preparation and pharmaceutical compositions containing them
06/28/1995EP0659428A1 2-Phenyl-3-azoylbenzothiophenes for treating obsessive-compulsive and consumptive disorders
06/28/1995EP0659421A1 2-Phenyl-3-azoylbenzothiophenes for treating menstrual symptoms
06/28/1995EP0659418A1 2-Phenyl-3-azoylbenzothiophene for treating Alzheimer's disease
06/28/1995EP0659415A2 Inhibition of vasomotor symptoms and treatment of psychological disturbances surrounding post-menopausal syndrome
06/28/1995EP0659413A2 Inhibition of CNS problems in post-menopausal women
06/28/1995EP0659412A2 Inhibition of the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
06/28/1995EP0659410A2 Use of the compound flupirtin against muscle bracing
1 ... 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 ... 1833